LDTs - G2 Intelligence

AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy

AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy

by Glenn S. Demby | May 22, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Must read

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Agency Streamlines Authorization of COVID-19 Molecular Test Pooling for Screening Programs

by Glenn S. Demby | May 19, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

MCIT Medicare Coverage Rule Could Be Reimbursement “Breakthrough” for Makers of LDTs

MCIT Medicare Coverage Rule Could Be Reimbursement “Breakthrough” for Makers of LDTs

by Glenn S. Demby | May 19, 2021 | Articles, CMS-nir, Compliance-nir, Essential, National Lab Reporter, Reimbursement-nir

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

AACC Guidelines Caution Against Using Serology Tests to Determine COVID-19 Vaccine Efficacy

by Glenn S. Demby | May 10, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

CMS Mulls Automatic Medicare Coverage of MCIT Breakthrough Devices

by Glenn S. Demby | May 10, 2021 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Reimbursement-dtet

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

« Older Entries

Next Entries »